Ars Pharmaceuticals, Inc. (SPRY) SEC Filings — 2024
18 SEC filings for Ars Pharmaceuticals, Inc. (SPRY) in 2024.
Filings
- ARS Pharma Files Q3 2024 10-Q/A Amendment — 10-Q/A · Dec 6, 2024
- ARS Pharma Files Q3 2024 10-Q — 10-Q · Nov 13, 2024
- ARS Pharmaceuticals Enters Material Definitive Agreement — 8-K · Nov 12, 2024
- ARS Pharmaceuticals Enters Material Definitive Agreement — 8-K · Oct 15, 2024
- ARS Pharmaceuticals Enters Material Definitive Agreement — 8-K · Sep 23, 2024
- ARS Pharmaceuticals Files 8-K — 8-K · Aug 12, 2024
- ARS Pharmaceuticals Files Q2 2024 10-Q — 10-Q · Aug 6, 2024
- ARS Pharmaceuticals Files 8-K — 8-K · Jun 28, 2024
- ARS Pharmaceuticals Reports Security Holder Vote — 8-K · Jun 21, 2024
- Pratik Shah Trust Amends ARS Pharma Stake — SC 13D/A · Jun 17, 2024
- Pratik Shah Trust Amends ARS Pharma Stake — SC 13D/A · Jun 11, 2024
- ARS Pharmaceuticals Files 8-K — 8-K · May 10, 2024
- ARS Pharmaceuticals Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 9, 2024
- ARS Pharmaceuticals, Inc. Announces 2024 Annual Meeting of Stockholders — DEF 14A · Apr 26, 2024
- RA Capital Management Amends ARS Pharma Stake — SC 13D/A · Mar 29, 2024
- ARS Pharmaceuticals, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 21, 2024
- ARS Pharmaceuticals Files 8-K — 8-K · Mar 7, 2024
- FMR LLC & Abigail Johnson Report 1.252% Stake in ARS Pharma — SC 13G/A · Feb 9, 2024